» Articles » PMID: 34356052

Roles of NcRNAs As CeRNAs in Gastric Cancer

Overview
Journal Genes (Basel)
Publisher MDPI
Date 2021 Aug 6
PMID 34356052
Citations 33
Authors
Affiliations
Soon will be listed here.
Abstract

Although ignored in the past, with the recent deepening of research, significant progress has been made in the field of non-coding RNAs (ncRNAs). Accumulating evidence has revealed that microRNA (miRNA) response elements regulate RNA. Long ncRNAs, circular RNAs, pseudogenes, miRNAs, and messenger RNAs (mRNAs) form a competitive endogenous RNA (ceRNA) network that plays an essential role in cancer and cardiovascular, neurodegenerative, and autoimmune diseases. Gastric cancer (GC) is one of the most common cancers, with a high degree of malignancy. Considerable progress has been made in understanding the molecular mechanism and treatment of GC, but GC's mortality rate is still high. Studies have shown a complex ceRNA crosstalk mechanism in GC. lncRNAs, circRNAs, and pseudogenes can interact with miRNAs to affect mRNA transcription. The study of the involvement of ceRNA in GC could improve our understanding of GC and lead to the identification of potential effective therapeutic targets. The research strategy for ceRNA is mainly to screen the different miRNAs, lncRNAs, circRNAs, pseudogenes, and mRNAs in each sample through microarray or sequencing technology, predict the ceRNA regulatory network, and, finally, conduct functional research on ceRNA. In this review, we briefly discuss the proposal and development of the ceRNA hypothesis and the biological function and principle of ceRNAs in GC, and briefly introduce the role of ncRNAs in the GC's ceRNA network.

Citing Articles

Comprehensive Multi-Omics Analysis Reveals NPC2 and ITGAV Genes as Potential Prognostic Biomarkers in Gastrointestinal Cancers.

Piroozkhah M, Zabihi M, Jalali P, Salehi Z Cancer Rep (Hoboken). 2024; 7(12):e70087.

PMID: 39690926 PMC: 11652787. DOI: 10.1002/cnr2.70087.


Comprehensive analysis identifies endocrine fibroblast growth factors as promising prognostic markers for colorectal carcinoma.

Rejali L, Piroozkhah M, Jahanbin M, Jalali P, Khanabadi B, Abkenar E Sci Rep. 2024; 14(1):28754.

PMID: 39567612 PMC: 11579457. DOI: 10.1038/s41598-024-79341-y.


Immunogenic cell death (ICD) genes predict immunotherapy response and therapeutic targets in acute myeloid leukemia (AML).

Wen S, Lv X, Ma X, Deng S, Xie J, Yuan E Front Genet. 2024; 15:1419819.

PMID: 39205940 PMC: 11349646. DOI: 10.3389/fgene.2024.1419819.


Acting mechanism and clinical significance of hsa_circ_0005927 in the invasion and metastasis of gastric cancer.

Shao Y, Yu X, Hu M, Yan J, Miao M, Ye G J Cancer. 2024; 15(13):4081-4094.

PMID: 38947400 PMC: 11212095. DOI: 10.7150/jca.96749.


Exploring the evolving roles and clinical significance of circRNAs in head and neck squamous cell carcinoma.

Lei P, Guo Q, Hao J, Liu H, Chen Y, Wu F J Cancer. 2024; 15(12):3984-3994.

PMID: 38911371 PMC: 11190751. DOI: 10.7150/jca.96614.


References
1.
Vangipuram R, Tyring S . AIDS-Associated Malignancies. Cancer Treat Res. 2018; 177:1-21. DOI: 10.1007/978-3-030-03502-0_1. View

2.
Dong X, Zhao Z, Hu Y, Lu Y, Liu P, Zhang L . LncRNA COL1A1-014 is involved in the progression of gastric cancer via regulating CXCL12-CXCR4 axis. Gastric Cancer. 2019; 23(2):260-272. DOI: 10.1007/s10120-019-01011-0. View

3.
Huang J, Chen Y, Zhang B . IGF2-AS affects the prognosis and metastasis of gastric adenocarcinoma via acting as a ceRNA of miR-503 to regulate SHOX2. Gastric Cancer. 2019; 23(1):23-38. DOI: 10.1007/s10120-019-00976-2. View

4.
Ma G, Liu H, Du M, Zhang G, Lin Y, Ge Y . A genetic variation in the CpG island of pseudogene GBAP1 promoter is associated with gastric cancer susceptibility. Cancer. 2019; 125(14):2465-2473. DOI: 10.1002/cncr.32081. View

5.
Miao Z, Guo X, Tian L . The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608. Gene. 2018; 687:116-124. DOI: 10.1016/j.gene.2018.11.052. View